Ferromax capsule: Each capsule contains Ferric Maltol INN 231.50 mg equivalent to 30mg Iron.
Ferromax delivers iron for uptake across the intestinal wall and transfer to transferrin and ferritin. It has been shown to increase serum iron parameters, including ferritin and transferrin saturation (TSAT).
Route of administration: Ferromax capsule should be taken in oral route, preferably on an empty stomach, at least 1 hour before or 2 hours after meals. Do not open, break or chew Ferromax capsule. The recommended dosage of Ferromax is 30 mg twice daily. Treatment duration will depend on the severity of iron deficiency but generally at least 12 weeks of treatment is required. The treatment should be continued as long as necessary until ferritin levels are within the normal range.
Preparation: Ferox ® 2 ml IV injection/infusion: Each 2 ml vial contains Ferric Carboxymaltose INN equivalent to Elemental Iron 100 mg. Ferox ® 10 ml IV injection/infusion: Each 10 ml vial contains Ferric Carboxymaltose INN equivalent to Elemental Iron 500 mg. Ferox ® 15 ml IV injection/infusion: Each 15 ml vial contains Ferric Carboxymaltose INN equivalent to Elemental Iron 750 mg. Ferox ® 20 ml IV injection/infusion: Each 20 ml vial contains Ferric Carboxymaltose INN equivalent to Elemental Iron 1 g.
Oral bisphosphonates, tetracyclines, and fluoroquinolones have reduced absorption when taken with iron (separate by 2-3 hours); dimercaprol increases toxic complex formation.
Ferric maltol is contraindicated in patients with known hypersensitivity to ferric maltol or any other components of this product. It is also contraindicated in patients with a history of hemochromatosis and other iron overload syndromes and in patients receiving repeated blood transfusions.
Common: Flatulence, diarrhea, constipation, discolored feces, abdominal pain, nausea, vomiting.
Overdose
No data is available regarding overdose of ferric maltol in patients. Early signs and symptoms of iron overdose may include nausea, vomiting, abdominal pain and diarrhea. In more serious cases there may be evidence of hypoperfusion, metabolic acidosis and systemic toxicity. Dosages of ferric maltol in excess of iron needs may lead to accumulation of iron in storage sites leading to hemosiderosis.
Category B. Not absorbed systemically as intact complex; maternal use not expected to cause fetal exposure. Lactation: Not absorbed systemically; breastfeeding not expected to result in infant exposure.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.